Statement: Patients do not need to have a known hormone receptor status to participate in the primary trial.
Primary_evidence: Inclusion Criteria:   Age: no limit   Karnofsky performance status (KPS)  70   No more than 5 metastatic sites involving one or more different organs (liver, lung or bone).   The size of the lesion must be such that it can be safely treated to sterilizing radiation doses according to the rules in the protocol.   Previously treated lesions are not eligible unless the prescribed dose can be safely delivered.   Concurrent therapy is allowed and recommended. The chemotherapy protocol type and schedule are at the discretion of the medical oncologist.   Informed consent must be obtained.   Pregnancy test must be negative for women of child bearing potential Exclusion Criteria:   Inability of patient to be followed longitudinally as specified by protocol.   Technical inability to achieve required dose based on safe dose constraints required for radiosurgery.   Women who are pregnant or nursing.   Failure to meet requirements in Inclusion Criteria   Contraindications to radiation.